Self-organizing neural networks for pharmacophore mapping

Advanced Drug Delivery Reviews

Volumn 55, Issue 9, 2003, Pages 1149-1162

  Polanski, Jaroslaw ^a  

^a UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SOFTWARE; DATA COMPRESSION; NEURAL NETWORKS;

SOFTWARE PACKAGES;

DRUG PRODUCTS;

BLOCKING AGENT; INTEGRASE; LIGAND; QUINOLINE DERIVATIVE; STYRYLQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTIFICIAL NEURAL NETWORK; DATA ANALYSIS; DRUG DESIGN; MOLECULAR MODEL; PHARMACOPHORE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STRUCTURE ANALYSIS; SURFACE PROPERTY;

EID: 0043235843     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(03)00116-9     Document Type: Article

References (66)

1. Sijbren O., Furlan R.L.E., Sanders J.K.M. Dynamic combinatorial chemistry. Drug Discov. Today. 7:2002;117-125.
2. Bures M.G. Recent techniques and applications in pharmacophore mapping. Charifson P.S. Practical Application of Computer-Aided Drug Design. 1997;39-72 Marcel Dekker Inc, New York.
3. Martin Y.C. Pharmacophore mapping. Martin Y.C., Willett P. Designing Bioactive Molecules Three-Dimensional Techniques and Applications. 1997;121-148 ACS, Washington, DC.
4. Koehler R.F., Rao S.N., Snyder J.P. Modeling drug-receptor interactions. Cohen N.C. Guidebook on Molceular Modeling in Drug Design. 1996;235-336 Academic Press.
5. van de Waterbeemd H., Carter R.E., Grassy G., Kubinyi H., Martin Y.C., Tute M.S., Willett P. Glossary of Terms Used in Computational Drug Design (IUPAC Recommendations 1997). Pure Appl. Chem. 69:1997;1137-1152.
6. Marchand-Geneste N., Watson K.A., Alsberg B.K., King R.D. New approach to pharmacophore mapping and QSAR analysis using inductive logic programming. Application to thermolysin inhibitors and glycogen phosphorylase B inhibitors. J. Med. Chem. 45:2002;399-409.
7. Kohonen T. Self-Organization and Associative Memory. 3rd Edition: 1989;Springer Verlag, Berlin.
8. Zupan J., Gesteiger J. Neural Networks in Chemistry and Drug Design. 2nd Edition: 1999;Wiley-VCH, Weinheim.
9. Melssen W.J., Smits J.R.M., Buydens L.M.C., Kateman G. Tutorial: Using artificial neural networks for solving chemical problems. Part II. Kohonen self-organising feature maps and Hopfield networks. Chemom. Intel. Lab. Syst. 23:1994;267-291.
10. Schneider G., Wrede P. Artificial neural networks for computer-based molecular design. Prog. Biophys. Mol. Biol. 70:1998;175-222.
11. T. Kohonen, The Self-Organizing Map (SOM), http://www.cis.hut.fi/projects/somtoolb.shtml.
12. Gerstein M., Greenbaum D., Luscombe M.N. What is bioinformatics? A proposed definition and overview of the field. Method Inform. Med. 40:2001;346-358.
13. Brazma A., Vilo J. Gene expression data analysis. FEBS Lett. 480:2000;17-24.
14. Toronen P., Kolehmainen M., Wong G., Castren E. Analysis of gene expression data using self-organizing maps. FEBS Lett. 451:1999;142-146.
15. Demuth H., Beale M. Neural Network Toolbox For Use with Matlab. 1998;The Mathworks Inc, Natick, MA.
16. J. Gesteiger, Self Organizing Neural Network for Information Analysis (SONNIA), Molecular Networks GmbH, http://www.mol-net.de/.
17. T. Kohonen, SOM Toolbox for Matlab, http://www.cis.hut.fi/projects/somtoolbox/.
18. M. Eisen, Cluster, http://rana.lbl.gov/EisenSoftware.htm.
19. Gasteiger J., Zupan J. Neural networks in chemistry. Angew. Chem. Int. Ed. Engl. 32:1993;503-527.
20. Gasteiger J., Li X., Rudolph Ch., Sadowski J., Zupan J. Representation of molecular electrostatic potentials by topological feature maps. J. Am. Chem. Soc. 116:1994;4608-4620.
21. Anzali S., Barnickel G., Krug M., Sadowski J., Wagener M., Gasteiger J., Polański J. The comparison of geometric and electronic properties of molecular surfaces by neural networks: Application to the analysis of corticosteroid binding globulin activity of steroids. J. Comput. Aided Mol. Des. 10:1996;521-534.
22. Jefford C.W., Grigorov M., Weber J., Lüthi H.P., Tronchet J.M.J. Correlating the molecular electrostatic potentials of some organic peroxides with their antimalarial activities. J. Chem. Inf. Comp. Sci. 40:2000;354-357.
23. Holzgrabe U., Wagener M., Gasteiger J. Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks. J. Mol. Graphics. 14:1996;185-193.
24. Gasteiger J., Holzgrabe U., Kostenis E., Mohr K., Sührig U., Wagener M. Variation of the oxime function of bispyridinium-type allosteric modulators of M2-cholinoceptors. Pharmazie. 50:1995;99-105.
25. L. Lockwood, C.M Breneman, M. Embrechts, K.P. Bennett, F. Arciniegas, Use of 2D, 3D, TAE and wavelet coefficient descriptors (WCDs) for generating self-organizing Kohonen maps for QSAR, QSPR, and ADME analyses, Abstracts of Papers of the American Chemical Society 220 (2000) 134-COMP Part 1.
26. Anzali S., Gasteiger J., Holzgrabe U., Polański J., Sadowski J., Teckentrup A., Wagener M. The use of self-organizing neural networks in drug design. Perspect. Drug Design Discov. 9/10/11:1998;273-299.
27. Burger A. Isosterism and bioisosterism in drug design. Ernstl J. Progress in Drug Research. Vol. 37:1991;287-371 Birkenhäuser Verlag, Basel.
28. Anzali S., Maderski W.W.K.R., Osswald M., Dorsch D. 1. Endothelin antagonists: A search for surrogates of methylendioxyphenyl by means of a Kohonen neural network. Bioorg. Med. Chem. Lett. 8:1998;11-16.
29. Maderski W.W.K.R., Osswald M., Dorsch D., Anzali S., Christadler M., Schmitages C.-J., Wilm C. 2. Endotelin antagonists: Evaluation of 2,1,3-benzotiadiazole as a methylendioxyphenyl bioisoster. Bioorg. Med. Chem. Lett. 8:1998;17-22.
30. Polański J., Gasteiger J., Jarzembek K. Self-organizing neural networks for screening and development of novel artificial sweetener candidates. Comb. Chem. High Throughput Screen. 3:2000;481-495.
31. Polański J., Jarzembek K. A search for new sulfonyl-containing glucophores. Pure Appl. Chem. 74:2002;1227-1233.
32. J. Polański, J. Gasteiger, The comparison of molecular surfaces by an assembly of self organizing neural network, 'Computers in Chemistry '94', Technical University of Wrocław, National Institute of Standards and Technology, Gaithersburg, MD, USA, Wrocław 1994, pp. 88-88.
33. Barlow T.W. Self-organizing maps and molecular similarity. J. Mol. Graphics. 13:1995;24-27.
34. Polański J., Gasteiger J., Wagener J., Sadowski J. The comparison of molecular surfaces by neural networks and its application to quantitative structure activity studies. Quant. Struct. Act. Relat. 17:1998;27-36.
35. Polański J. The non-grid method for modeling 3D QSAR using self-organizing neural networks (SOM) and PLS analysis: Application to steroids and colchicinoids. SAR QSAR Environ. Res. 11:2000;245-261.
36. Polański J., Gasteiger J. Self-organizing neural networks for visualization and quantification of molecular similarity. Acta Pol. Pharm. 56:1999;112-122.
37. Polański J. Self-organizing neural network for modeling 3D QSAR of colchicinoids. Acta Bioch. Pol. 47:2000;37-45.
38. Anzali S., Barnickel G., Krug M., Sadowski J., Wagener M., Gasteiger J. Evaluation of molecular surface properties using a Kohonen neural network: Studies of structure-activity relationship. Devillers J. Neural Networks in QSAR and Drug Design. 1996;209-222 Academic Press, London.
39. Wagener M., Sadowski J., Gasteiger J. Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J. Am. Chem. Soc. 117:1995;7769-7775.
40. J. Polański, Molecular Shape Analysis, in: J. Gasteiger (Ed.), Handbook of Chemoinformatics from Data to Knowledge, Wiley-VCH, Weinheim, 2003, pp. 302-319.
41. Polański J., Gieleciak R., Bak A. The Comparative Molecular Surface Analysis (COMSA) - A nongrid 3D QSAR method by a coupled neural network and PLS system: Predicting pK(a) values of benzoic and alkanoic acids. J. Chem. Inf. Comput. Sci. 42:2002;184-191.
42. Chen J.C.-H., Krucinski J., Miercke L.J.W., Finer-Moore J.S., Tang A.H., Leavitt A.D., Stroud R.M. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding. Proc. Natl. Acad. Sci. USA. 97:2000;8233-8238.
43. Hazuda D.J., Felock P., Witmer M., Wolfe A., Stillmock K., Grobler J.A., Espeseth A., Gabryelski L., Schleif W., Blau C., Miller M.D. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science. 287:2000;646-650.
44. Mekouar K., Mouscadet J.F., Desmaële D., Subra F., Leh H., Savouré D., Auclair C., d'Angelo J. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. J. Med. Chem. 41:1998;2846-2857.
45. Zouhiri F., Mouscadet J.F., Mekouar Kh., Desmaële D., Savouré D., Leh H., Subra F., Le Bret M., Auclair C., d'Angelo J. Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1-integrase and replication of HIV-1 in cell culture. J. Med. Chem. 43:2000;1533-1540.
46. Ouali M., Laboulais C., Leh H., Gill D., Desmaële D., Mekouar K., Zouhiri F., d'Angelo J., Auclair C., Mouscadet J.F., Le Bret M. Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives. J. Med. Chem. 43:2000;1949-1957.
47. Ouali M., Laboulais C., Leh H., Gill D., Xhuvani E., Zouhiri F., Desmaële D., d'Angelo J., Auclair C., Mouscadet J.F., Le Bret M. Tautomers of styrylquinoline derivatives containing a methoxy substituent: computation of their population in aqueous solution and their interaction with RSV integrase catalytic core. Acta Bioch. Pol. 47:2000;11-22.
48. Polański J., Zouhiri F., Jeanson L., Desmaële D., d'Angelo J., Mouscadet J.-F., Gieleciak R., Gasteiger J., Le Bret M. Use of the Kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines. J. Med. Chem. 45:2002;4647-4654.
49. Cramer R.D., Petterson D.E., Bunce J.D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110:1988;5959-5967.
50. Hahn M., Rogers D. Receptor surface models. Perspect. Drug Discov. Design. 12/13/14:1998;117-133.
51. Kubinyi H., Folkers G., Martin Y.C. 3D QSAR In Drug Design. Recent Advances. Vol. 3:1998;Kluwer/ ESCOM, Dordrecht.
52. Ivanciuc O., Ivanciuc T., Cabrol-Bass D. 3D quantitative structure activity relationships with CoRSA. Comparative Receptor Surface Analysis. Application to calcium chanel agonists. Analysis. 28:2000;637-642.
53. Polański J. The mapping of the molecular surfaces by means of self-organizing neural networks within MATLAB 5.2 for WINDOWS-95. Acta Pol. Pharm. 56:1999;80-84.
54. Polański J., Walczak B. The Comparative Molecular Surface Analysis by self-organizing neural network and PLS analysis. Comput. Chem. 24:2000;615-625.
55. Polański J., Gieleciak R., Bak A., Jarzembek K., Wyszomirski M. The Comparative Molecular Surface Analysis (CoMSA) a new efficient technique for drug design. Acta Pol. Pharm. 59:2002;459-461.
56. Fujita T., Nishioka T. The analysis of the ortho effect. Prog. Phys. Org. Chem. 12:1976;49.
57. Hansch C., Leo A. Exploring QSAR Fundamentals and Applications in Chemistry and Biology. 1995;88-89 ACS, Washington DC.
58. Polański J. The receptor-like neural network for modeling corticosteroid and testosterone binding globulins. J. Chem. Inf. Comp. Sci. 37:1997;553-561.
59. Polański J. Neural nets for the simulation of the molecular recognition within MS-WINDOWS environment. J. Chem. Inf. Comp. Sci. 36:1996;694-705.
60. Polański J. A neural network for the simulation of biological systems. J. Mol. Struct. (Theochem.). 398-399:1997;567-571.
61. Polański J., Ratajczak A., Gasteiger J., Galdecki Z., Galdecka E. Molecular modeling and X-ray analysis for the structure-taste study of arylsulfonylalkanoic acids. J. Mol. Struct. 407:1997;71-80.
62. Silverman B.D. Molecular moments for computer-aided drug discovery. Mini Rev. Med. Chem. 1:2001;1-4.
63. Vedani A., Dobler M. Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters. Jucker E. Progress in Drug Research. Vol. 55:2000;105-135 Birkhäuser, Basel.
64. Hopfinger A.J., Wang S., Tokarski J.S., Jin B., Albuquerque M., Madhav P.J., Duraiswami C. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J. Am. Chem. Soc. 119:1997;10509-10524.
65. Hopfinger A.J. A QSAR investigation of dihydrofolate reductase inhibitors by Baker triazines based upon molecular shape analysis. J. Am. Chem. Soc. 102:1980;7196-7206.
66. a values and steroid CBG binding affinities, J. Chem. Inf. Comput. Sci., sent for publication.